2019
DOI: 10.1016/j.bioorg.2019.03.053
|View full text |Cite
|
Sign up to set email alerts
|

Dual targeting of PTP1B and glucosidases with new bifunctional iminosugar inhibitors to address type 2 diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 66 publications
1
19
0
Order By: Relevance
“…The above results are broadly in line with those reported by Guisot et al, who conceived to evaluate a library of DNJ derivatives 17-23 ( Figure 6), in which triazole-bearing alkyl chains were introduced to link an adamantane moiety to the iminosugar core [98]. This project stands on the intriguing therapeutic potential of AMP-DNM (16) [99][100][101][102], even though it must be noted that, to the best of our knowledge, the latter has never been tested as a CFTR corrector. The above results are broadly in line with those reported by Guisot et al, who conceived to evaluate a library of DNJ derivatives 17-23 ( Figure 6), in which triazole-bearing alkyl chains were introduced to link an adamantane moiety to the iminosugar core [98].…”
Section: N-alkyl Dnj Derivatives: Studying the Role Of Lipophilicity supporting
confidence: 88%
See 2 more Smart Citations
“…The above results are broadly in line with those reported by Guisot et al, who conceived to evaluate a library of DNJ derivatives 17-23 ( Figure 6), in which triazole-bearing alkyl chains were introduced to link an adamantane moiety to the iminosugar core [98]. This project stands on the intriguing therapeutic potential of AMP-DNM (16) [99][100][101][102], even though it must be noted that, to the best of our knowledge, the latter has never been tested as a CFTR corrector. The above results are broadly in line with those reported by Guisot et al, who conceived to evaluate a library of DNJ derivatives 17-23 ( Figure 6), in which triazole-bearing alkyl chains were introduced to link an adamantane moiety to the iminosugar core [98].…”
Section: N-alkyl Dnj Derivatives: Studying the Role Of Lipophilicity supporting
confidence: 88%
“…The first recognized property of iminosugars was their ability to act as glycosidase [5,7] and glycosyltransferase inhibitors [9,10], essentially acting in a competitive manner and exerting their activity mainly as antivirals (HIV-1, HSV, BVDV, HCV) [11,12] and antidiabetics [13][14][15][16]. Furthermore, they were also found to inhibit other classes of enzymes, such as metalloproteinases [17], sugar nucleotide mutase or nucleoside-processing enzymes [18][19][20].…”
Section: Iminosugars: Powerful Glycomimeticsmentioning
confidence: 99%
See 1 more Smart Citation
“…As an alternative deprotection procedure, the cycloadduct 11 was treated with a BCl 3 solution in dry CH 2 Cl 2 at room temperature 16 h and the crude reaction mixture was directly reacted with an excess of acetic anhydride in pyridine, affording the peracetylated compound 15 in 95 % yield over two steps. In analogy with the peculiar reactivity of BCl 3 towards the N‐O bonds in nitrones, in N ‐hydroxypyrrolidines and in nitro compounds, the N‐O bond of isoxazolidine 11 was not cleaved with this reagent.…”
Section: Resultsmentioning
confidence: 95%
“…In contrast, construction of monocyclic pyrrolidine iminosugars with only four chiral centres are easier to accomplish. The pyrrolidine core of the corresponding iminosugar frequently appears to be the HexNAcase pharmacophore [37][38][39], as the pyrrolidine sections are responsible for mimicking the transition-state of enzyme reaction [40]. Among these monocyclic iminosugars, a series of pyrrolidines containing acetamide groups which are essential for their β-HexNAcase inhibitions were reported (Figure 2), among which considerable examples were accomplished before the isolation of pochonicine (1) [41,42].…”
Section: Introductionmentioning
confidence: 99%